• Like

Global Companion Diagnostic Technologies Market (indication and geography) size, share, global trends, company profiles, demand, insights, analysis, research, report, opportunities, segmentation and forecast, 2013 - 2020

  • 121 views
Uploaded on

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is …

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
121
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Global Companion Diagnostic (CD) Market is Expected to Reach $3.5 Billion by 2020
  • 2. Published Date: 03 May 2014 107 Pages Report Published Date : 10 June 2014
  • 3. Table of Content 1. Introduction 2. Executive Summary 3. Global 3D Technology Market Overview 4. Global 3D Technology Market by Products 5. Global 3D Technology Market by Applications 6. Global 3D Technology Market by Geography 7. Company Profiles Introduction Scope of the Report Key Benefits Key Audiences
  • 4. Description Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Geographically, LAMEA is the fastest growing region. The key drivers for this market are the increase in the discovery of biomarkers and co-development of drug and corresponding diagnostic. However, cost associated with developing drugs could impede the growth of this market. Opportunities for this market lie in developing companion diagnostics for various central nervous system conditions and hereditary conditions.
  • 5. Assessments are made according to the current business scenario and the future market trends are forecast for the period 2013-2020, with the base figures of the year 2013 The analysis gives a wider view of the global market including its market trends, market structure, limiting factors and opportunities for the market Porter’s five force’s model helps in analyzing the potential of buyers & suppliers, and the competitive sketch of the market, which would guide the market players to develop strategies accordingly The value chain analysis provides a systematic study on the key intermediaries involved, which would in turn help the stakeholders in the market to make appropriate strategies The advantages of the market are analyzed to help the stakeholders identify the opportunistic areas in a comprehensive manner KEY BENEFITS
  • 6. Companion Diagnostic Technologies Market Analysis Companion Diagnostics Indication Market Analysis Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. Companion Diagnostics Technology Market Analysis Companion diagnostics technology market is segmented into Immunohistochemistry and Molecular diagnostics. Molecular diagnostics would be the fastest growing and highest revenue generator, mainly due to the use of techniques such as real time PCR, In Situ Hybridization and next generation sequencing. Other factors contributing to the growth is technological advancements in molecular diagnostics, which has resulted in increased accuracy and precision and also reduced cost of testing using these methods. Companion Diagnostics Geography Market Analysis Companion Diagnostics market has been segmented geographically into North America, Europe, Asia Pacific and LAMEA. North America has the major market share of 43.97% followed by Europe, which accounted for about 38% of the overall CD market in 2013. North America and Europe together accounted for over 82% in the global CD market in 2013 and they would continue to be the major markets through 2020.
  • 7. Companion Diagnostic Technologies Market Competitive Analysis & High Level Analysis Competitive Analysis A study of some of the key players has showed that majority of the companies in this market are focusing on collaborations with drug companies. Companion diagnostics is a emerging market and companies are collaborating with drug companies to develop companion diagnostics for their pipeline drugs, which are in developing phase. Approvals for companion diagnostics are the second most popular strategy. Companies profiled in this report include Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, Inc., Ventana Medical Systems, bioMerieux, Myriad Genetics, Inc., Resonance Health Ltd., Leica Microsystems, and Life Technologies. High Level Analysis The report is focusing on the trends in technology and diagnosis of various indications, which are driving the growth of the companion diagnostics market. Analysis of the market based on porters five force model shows that the bargaining power of the suppliers is high as the products produced are highly differentiated. The threat of new entrants is low as significant research and development is required for developing diagnostic tests. Apart from the R&D requirements, the investment required is also high. These factors make it difficult for new companies to enter the market. The threat of substitutes is low in this market as companion diagnostics are developed for specific biomarkers and the products are highly differentiated. Competition in this market is moderate as the market is still emerging and there are a few companies in the market. Government regulations are favoring use of companion diagnostics for determining a particular treatment.
  • 8. 1. Introduction 2. Executive Summary 3. Market Overview 4. Global Companion Diagnostic Market by Indications 5. Global Companion Diagnostic Market by Technology 6. Global Companion Diagnostic Market by Geography 7. Company Profiles Table of Contents
  • 9. Global Companion Diagnostic Technologies Market Overview Value Chain Analysis Companion Diagnostic Technologies Market Overview Government Regulations Market Definition and Scope Companion Diagnostics for Metabolic Diseases Companion diagnostics as a new trend in personalized medicine Novel trends & technologies in companion diagnostics assay development Porter’s five forces analysis Key Findings
  • 10. Your feedback is important to us What would you like to know more about this Study ?  Global Industry Analysis  Market Size  Market Share  Market Trends Opportunities and Forecast Please inform us on : http://www.alliedmarketresearch.com/contact-us Market Dynamics Key Market Drivers Market Restraints High Cost in research and development of drugs Market Dynamics Increase in the Discovery of Biomarkers as drug targets. Technological advancements Increasing cases of adverse drug reactions(ADR) Increased popularity of Personalized medicine Economic and scientific obstacles Low price of competing technologies
  • 11. Companion Diagnostic Market By Indications Companion Diagnostic Market By Indications Oncology Others Inflammation and Auto- immune diseases Companion diagnostics in cardiovascular diseases Companion diagnostics in CNS disorders Companion diagnostics tests in virology diseases Others
  • 12. Companion Diagnostic Market By Technology Immunohist ochemistry Molecular Diagnostics Others Global Companion Diagnostic Market By Technology
  • 13. Top Market Players of Companion Diagnostic Market  Qiagen  Dako (Agilent Technologies)  Roche  Abbott Laboratories, Inc.  BioMerieux  Ventana Medical Systems  Myriad Genetics, Inc.  Resonance Health Ltd  Leica Microsystems  Life Technologies
  • 14. Your feedback is important to us What would you like to know more about this Study ?  Global Industry Analysis  Market Size  Market Share  Market Trends Opportunities and Forecast Please inform us on : http://www.alliedmarketresearch.com/contact-us
  • 15. http://www.alliedmarketresearch. com/ companion-diagnostic- technologies-market